Aljosja Rogiers

Toward Minimal Residual Disease-Directed Therapy in Melanoma

Florian Rambow, Aljosja Rogiers, Oskar Marín-Béjar et al. · Cell · 2018 · 771 citations · Full text

Medicine, Dermatology, Oncology +12

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Annika Fendler, Scott T.C. Shepherd, Lewis Au et al. · Nature Cancer · 2021 · 185 citations · Full text

Life Sciences, Immunology, Oncology +13

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

Charles C. Bell, Katie Fennell, Yih-Chih Chan et al. · Nature Communications · 2019 · 180 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth

Michael Dewaele, Tommaso Tabaglio, Karen Willekens et al. · Journal of Clinical Investigation · 2015 · 170 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Oskar Marín-Béjar, Aljosja Rogiers, Michael Dewaele et al. · Cancer Cell · 2021 · 154 citations · Full text

Life Sciences, Genetics, Oncology +14